Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.

Machine translation Machine translation
类别 Primary study
期刊Chemotherapy
Year 2004
連結 Pubmed, DOI

此文章收錄於 2 Systematic reviews Systematic reviews (2 references)

Loading references information
对发热病人124例恶性血液病进行一个前瞻性，随机，双盲试验，比较与万古霉素，替考除了最初的经验性丁胺卡那霉素，头孢他啶后，记录菌血症由于革兰氏阳性球菌的方案。在入学，两组患者年龄，性别方面的可比性，相关血液疾病和中性粒细胞减少的持续时间。治疗成功率分别为55/63（87.3％），替考拉宁组和万古霉素组（P = 0.560），56/61（91.8％）。平均治疗时间相似，分别为12.2和11.4天（P = 0.216）。与替考拉宁治疗的患者仍略高于万古霉素（4.9 - 4.0天）（P = 0.013），治疗这些发热。13例患者经历了药品不良反应，但没有任何两手臂显着差异。隔离葡萄球菌表现出易感性的进步和显着的下降，在多年研究的两种糖肽。进行的经济分析表明，除万古霉素是节约成本。
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: 3c25f86e5b208d0cc35ae1424f0d04fcb7da4d8a
First added on: Jun 08, 2011
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use